A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Designing for Senior Care Communities Means Designing for Everyone
Harlem Hospital Legionnaires' Outbreak Highlights Cooling Tower Risks
WelbeHealth Opens Two New Centers in California
Healthcare Security: To Arm Or Not To Arm?
False Alarm at Kansas Hospital Highlights Importance of Alarm System Reliability